Covishield Covaxin
-
{
- All
- News
- Videos
-
'Awaiting Lifting Of Curbs...': New Zealand's Nod To Covaxin, Covishield
New Zealand has included Covaxin and Covishield to its list of eight approved vaccines, Indian High Commissioner to the country, Mukhtesh Pardeshi, said today.
-
Vaccination Certificates Via CoWIN For Covishield, Covaxin Trial Participants
The participants in the clinical trials of Covishield and Covaxin have received their Covid vaccination certificates through the CoWIN app, the Centre has said. Union Health Minister Mansukh Mandaviya thanked their contribution during the pandemic.
-
Study On Mixing Covaxin, Covishield Gets Drug Regulator Approval
A study on mixing Covishield and Covaxin, the two main vaccines used in India's COVID-19 vaccination programme, has been given the go-ahead by the Drugs Controller General Of India (DCGI).
-
Marginal Difference In Covishield, Covaxin Purchase Price for Centre: Government
The Centre is purchasing Covishield and Covaxin doses at the rate of Rs 205 and Rs 215 per dose, respectively, and there is only a marginal difference in the purchase price of the two vaccines for the government, the Lok Sabha was informed on Friday.
-
Centre To Buy 66 Crore More Doses Of Covishield, Covaxin At Revised Rates: Report
The Centre has placed an order to procure 66 crore more doses of Covishield and Covaxin to be supplied between August and December this year, at a revised price of Rs 205 and Rs 215 per dose, respectively, excluding taxes, official sources said.
-
To Stop 3rd Wave, India Needs 8.6 Million Jabs A Day. Actual Rate Is...
Having seen off a deadly second wave of coronavirus infections, India is now praying that a third wave doesn't emerge to rampage through the country.
-
Nearly 25 Crore Vaccine Doses Likely By August: Central Covid Panel
With ramping up of production capacities, nearly 25 crore 'Made in India' vaccines are expected to be available by August, a senior official has said and noted that it will go a long way in meeting the target of vaccinating one crore people daily aga
-
Covishield, Covaxin Effective Against 'Indian Strain' Of Coronavirus: Study
Covishield and Covaxin -- the two coronavirus vaccines currently in use in India -- have efficacy against the "Indian strain" and show "milder" illness in case of infection post vaccination
-
Over 1,700 Doses Of COVID-19 Vaccines Stolen From Haryana Hospital
Over 1,700 doses of COVID-19 vaccine were stolen from a government hospital in Haryana's Jind, a police official said today.
-
Sputnik V, Covishield, Covaxin: All About Vaccines Approved In India
The Drug Controller General of India (DCGI) approved the Sputnik V vaccine for emergency use in India on Tuesday.
-
India To Review Vaccine Side Effects Amid Blood Clot Concerns: Report
A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered in India, financial daily Mint reported on Friday.
-
Covaxin's Production Capacity 150 Million Doses A Year: Centre
The estimated manufacturing capacity of COVID-19 vaccine, Covishield, is 70-100 million doses per month, while the indigenously developed Covaxin has a planned production capacity of 150 million doses per year, the Department of Biotechnology told a parliamentary panel.
-
India Starts Commercial Covid Vaccine Exports Today
The government has cleared commercial exports of COVID-19 vaccines, with the first consignments to be shipped to Brazil and Morocco on Friday, the foreign secretary told Reuters.
-
Covishield, Covaxin Safe, Side-Effects Negligible: NITI Aayog Member
Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member (Health), NITI Aayog, said on Tuesday and noted that the two "are safest of the vaccines".
-
Covid Vaccine Recipients Will Not Get To Choose From 2 Options For Now: Centre
The government hinted on Tuesday that for now, the COVID vaccine recipients will not have the option to choose from the two vaccines recently approved for restricted emergency use in India.
-
'Awaiting Lifting Of Curbs...': New Zealand's Nod To Covaxin, Covishield
New Zealand has included Covaxin and Covishield to its list of eight approved vaccines, Indian High Commissioner to the country, Mukhtesh Pardeshi, said today.
-
Vaccination Certificates Via CoWIN For Covishield, Covaxin Trial Participants
The participants in the clinical trials of Covishield and Covaxin have received their Covid vaccination certificates through the CoWIN app, the Centre has said. Union Health Minister Mansukh Mandaviya thanked their contribution during the pandemic.
-
Study On Mixing Covaxin, Covishield Gets Drug Regulator Approval
A study on mixing Covishield and Covaxin, the two main vaccines used in India's COVID-19 vaccination programme, has been given the go-ahead by the Drugs Controller General Of India (DCGI).
-
Marginal Difference In Covishield, Covaxin Purchase Price for Centre: Government
The Centre is purchasing Covishield and Covaxin doses at the rate of Rs 205 and Rs 215 per dose, respectively, and there is only a marginal difference in the purchase price of the two vaccines for the government, the Lok Sabha was informed on Friday.
-
Centre To Buy 66 Crore More Doses Of Covishield, Covaxin At Revised Rates: Report
The Centre has placed an order to procure 66 crore more doses of Covishield and Covaxin to be supplied between August and December this year, at a revised price of Rs 205 and Rs 215 per dose, respectively, excluding taxes, official sources said.
-
To Stop 3rd Wave, India Needs 8.6 Million Jabs A Day. Actual Rate Is...
Having seen off a deadly second wave of coronavirus infections, India is now praying that a third wave doesn't emerge to rampage through the country.
-
Nearly 25 Crore Vaccine Doses Likely By August: Central Covid Panel
With ramping up of production capacities, nearly 25 crore 'Made in India' vaccines are expected to be available by August, a senior official has said and noted that it will go a long way in meeting the target of vaccinating one crore people daily aga
-
Covishield, Covaxin Effective Against 'Indian Strain' Of Coronavirus: Study
Covishield and Covaxin -- the two coronavirus vaccines currently in use in India -- have efficacy against the "Indian strain" and show "milder" illness in case of infection post vaccination
-
Over 1,700 Doses Of COVID-19 Vaccines Stolen From Haryana Hospital
Over 1,700 doses of COVID-19 vaccine were stolen from a government hospital in Haryana's Jind, a police official said today.
-
Sputnik V, Covishield, Covaxin: All About Vaccines Approved In India
The Drug Controller General of India (DCGI) approved the Sputnik V vaccine for emergency use in India on Tuesday.
-
India To Review Vaccine Side Effects Amid Blood Clot Concerns: Report
A government panel of experts is investigating for any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered in India, financial daily Mint reported on Friday.
-
Covaxin's Production Capacity 150 Million Doses A Year: Centre
The estimated manufacturing capacity of COVID-19 vaccine, Covishield, is 70-100 million doses per month, while the indigenously developed Covaxin has a planned production capacity of 150 million doses per year, the Department of Biotechnology told a parliamentary panel.
-
India Starts Commercial Covid Vaccine Exports Today
The government has cleared commercial exports of COVID-19 vaccines, with the first consignments to be shipped to Brazil and Morocco on Friday, the foreign secretary told Reuters.
-
Covishield, Covaxin Safe, Side-Effects Negligible: NITI Aayog Member
Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member (Health), NITI Aayog, said on Tuesday and noted that the two "are safest of the vaccines".
-
Covid Vaccine Recipients Will Not Get To Choose From 2 Options For Now: Centre
The government hinted on Tuesday that for now, the COVID vaccine recipients will not have the option to choose from the two vaccines recently approved for restricted emergency use in India.
